Bajaj Healthcare credit ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
233233223332414
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
195195218329397
0.44×0.44×0.48×1.19×1.13×
0.37×0.37×0.47×1.18×1.08×
2.23×2.23×2.70×4.35×3.88×
1.73×1.86×2.65×4.32×3.71×
3.48×3.48×1.95×1.64×3.48×
29.5%30.5%32.3%54.4%53.0%
As filed — company-reported covenants
48.00×44.00×0.48×——
226.00×215.00×0.44×——
409.00×380.00×3.65×——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAJAJHCARE₹312.85

Bajaj Healthcare Limited

· Pharma & Health
₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,053 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Total Debt414.3332.1222.6233.5233.5
Net Debt396.6329.1218.2195.5195.5
Total Debt/Equity1.131.190.480.440.44
Net Debt/Equity1.081.180.470.370.37
Total Debt/EBITDA3.884.352.702.232.23
Net Debt/EBITDA3.714.322.651.861.73
Interest Coverage (EBIT/Interest)3.481.641.953.483.48
Total Debt/Total Capital %52.9854.4032.3230.4629.53
As Filed — company-reported covenants
Debt/Equity (as filed)——0.4844.0048.00
Debt Service Coverage (as filed)——0.44215.00226.00
Interest Service Coverage (as filed)——3.65380.00409.00
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.